- Eli Lilly, Novo Nordisk, and Amgen are leading the weight-loss medicine niche and are considered stock leaders.
- Hims & Hers and Eucalyptus expand internationally through a partnership granting access to branded GLP-1 medications.
Hims & Hers Health completed its largest acquisition in company history, involving Eucalyptus.
3 reports, 3 independent
Updated Oct 12
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hims & Hers Health completed its largest acquisition in company history, involving Eucalyptus.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hims & Hers Health
American telehealth company
Nothing else this week.
-
Eucalyptus
private educational institution in Morocco
Nothing else this week.